Completed OBSERVATIONAL NCT05074043
COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital
Sponsor: Assiut University
Conditions
Mucormycosis
Interventions
antiviral, surgical
Updated 3 times since 2021 Last updated: Oct 5, 2021 Started: Mar 1, 2021 Primary completion: Jun 30, 2021 Completion: Jul 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT05074043, this observational or N/A phase trial focuses on Mucormycosis and remains completed. Sponsored by Assiut University, it has been updated 3 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2021 — Jul 2024 [monthly]
Completed
First recorded
Mar 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Assiut University
Data source: Assiut University
For direct contact, visit the study record on ClinicalTrials.gov .